<?xml version='1.0' encoding='utf-8'?>
<document id="31773191"><sentence text="Concomitant use of drugs known to cause interactions with oral antiplatelets-polypharmacy in acute coronary syndrome outpatients in Finland." /><sentence text="Use of oral antiplatelets (OAPs) is essential for preventing thrombotic events in patients with acute coronary syndrome (ACS)" /><sentence text=" Effects of clopidogrel, prasugrel, and ticagrelor may be enhanced due to pharmacodynamic interactions, but as CYP substrates, they are prone to pharmacokinetic interactions too"><entity charOffset="12-23" id="DDI-PubMed.31773191.s3.e0" text="clopidogrel" /><entity charOffset="25-34" id="DDI-PubMed.31773191.s3.e1" text="prasugrel" /><entity charOffset="40-50" id="DDI-PubMed.31773191.s3.e2" text="ticagrelor" /><pair ddi="false" e1="DDI-PubMed.31773191.s3.e0" e2="DDI-PubMed.31773191.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31773191.s3.e0" e2="DDI-PubMed.31773191.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31773191.s3.e0" e2="DDI-PubMed.31773191.s3.e2" /><pair ddi="false" e1="DDI-PubMed.31773191.s3.e1" e2="DDI-PubMed.31773191.s3.e1" /><pair ddi="false" e1="DDI-PubMed.31773191.s3.e1" e2="DDI-PubMed.31773191.s3.e2" /></sentence><sentence text=" The aim was to study polypharmacy in ACS patients following hospital discharge" /><sentence text="" /><sentence text="This observational drug utilization study linked patient-level data from nationwide registers" /><sentence text=" The study population consisted of adult ACS patients discharged from Finnish hospitals in 2009-2013" /><sentence text=" Logistic regression was used to model the probability of drug-drug interactions with odd ratios for predefined predictors such as age, gender, and ACS type" /><sentence text="" /><sentence text="In the cohort of 54,416 ACS patients, 91% of those treated with OAP received clopidogrel"><entity charOffset="77-88" id="DDI-PubMed.31773191.s10.e0" text="clopidogrel" /></sentence><sentence text=" Of clopidogrel-treated patients, 12% purchased warfarin at least once while on clopidogrel treatment"><entity charOffset="4-15" id="DDI-PubMed.31773191.s11.e0" text="clopidogrel" /><entity charOffset="80-91" id="DDI-PubMed.31773191.s11.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.31773191.s11.e0" e2="DDI-PubMed.31773191.s11.e0" /><pair ddi="false" e1="DDI-PubMed.31773191.s11.e0" e2="DDI-PubMed.31773191.s11.e1" /></sentence><sentence text=" Old age, male sex, ST-elevation myocardial infarction as index event, and a history of previous ACS events were associated with an increased risk of warfarin-OAP interaction (p &lt; 0" /><sentence text="001 for all)" /><sentence text=" Ibuprofen, and serotonergic drugs tramadol, citalopram, and escitalopram were the next most common drugs causing pharmacodynamic interactions"><entity charOffset="1-10" id="DDI-PubMed.31773191.s14.e0" text="Ibuprofen" /><entity charOffset="35-43" id="DDI-PubMed.31773191.s14.e1" text="tramadol" /><entity charOffset="45-55" id="DDI-PubMed.31773191.s14.e2" text="citalopram" /><entity charOffset="61-73" id="DDI-PubMed.31773191.s14.e3" text="escitalopram" /><pair ddi="false" e1="DDI-PubMed.31773191.s14.e0" e2="DDI-PubMed.31773191.s14.e0" /><pair ddi="false" e1="DDI-PubMed.31773191.s14.e0" e2="DDI-PubMed.31773191.s14.e1" /><pair ddi="false" e1="DDI-PubMed.31773191.s14.e0" e2="DDI-PubMed.31773191.s14.e2" /><pair ddi="false" e1="DDI-PubMed.31773191.s14.e0" e2="DDI-PubMed.31773191.s14.e3" /><pair ddi="false" e1="DDI-PubMed.31773191.s14.e1" e2="DDI-PubMed.31773191.s14.e1" /><pair ddi="false" e1="DDI-PubMed.31773191.s14.e1" e2="DDI-PubMed.31773191.s14.e2" /><pair ddi="false" e1="DDI-PubMed.31773191.s14.e1" e2="DDI-PubMed.31773191.s14.e3" /><pair ddi="false" e1="DDI-PubMed.31773191.s14.e2" e2="DDI-PubMed.31773191.s14.e2" /><pair ddi="false" e1="DDI-PubMed.31773191.s14.e2" e2="DDI-PubMed.31773191.s14.e3" /></sentence><sentence text=" In general, concomitant use of drugs known to cause pharmacokinetic interactions was rare, but both esomeprazole and omeprazole were prescribed in more than 6% of clopidogrel-treated patients"><entity charOffset="101-113" id="DDI-PubMed.31773191.s15.e0" text="esomeprazole" /><entity charOffset="118-128" id="DDI-PubMed.31773191.s15.e1" text="omeprazole" /><entity charOffset="164-175" id="DDI-PubMed.31773191.s15.e2" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.31773191.s15.e0" e2="DDI-PubMed.31773191.s15.e0" /><pair ddi="false" e1="DDI-PubMed.31773191.s15.e0" e2="DDI-PubMed.31773191.s15.e1" /><pair ddi="false" e1="DDI-PubMed.31773191.s15.e0" e2="DDI-PubMed.31773191.s15.e2" /><pair ddi="false" e1="DDI-PubMed.31773191.s15.e1" e2="DDI-PubMed.31773191.s15.e1" /><pair ddi="false" e1="DDI-PubMed.31773191.s15.e1" e2="DDI-PubMed.31773191.s15.e2" /></sentence><sentence text="" /><sentence text="Warfarin and ibuprofen were the most commonly used concomitant medications causing pharmacodynamic interactions and potentially increasing the risk of bleeding in OAP-treated patients"><entity charOffset="0-8" id="DDI-PubMed.31773191.s17.e0" text="Warfarin" /><entity charOffset="13-22" id="DDI-PubMed.31773191.s17.e1" text="ibuprofen" /><pair ddi="false" e1="DDI-PubMed.31773191.s17.e0" e2="DDI-PubMed.31773191.s17.e0" /><pair ddi="false" e1="DDI-PubMed.31773191.s17.e0" e2="DDI-PubMed.31773191.s17.e1" /></sentence><sentence text=" Esomeprazole and omeprazole were used in clopidogrel-treated patients although there are alternatives available for gastric protection"><entity charOffset="1-13" id="DDI-PubMed.31773191.s18.e0" text="Esomeprazole" /><entity charOffset="18-28" id="DDI-PubMed.31773191.s18.e1" text="omeprazole" /><entity charOffset="42-53" id="DDI-PubMed.31773191.s18.e2" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.31773191.s18.e0" e2="DDI-PubMed.31773191.s18.e0" /><pair ddi="false" e1="DDI-PubMed.31773191.s18.e0" e2="DDI-PubMed.31773191.s18.e1" /><pair ddi="false" e1="DDI-PubMed.31773191.s18.e0" e2="DDI-PubMed.31773191.s18.e2" /><pair ddi="false" e1="DDI-PubMed.31773191.s18.e1" e2="DDI-PubMed.31773191.s18.e1" /><pair ddi="false" e1="DDI-PubMed.31773191.s18.e1" e2="DDI-PubMed.31773191.s18.e2" /></sentence><sentence text="" /></document>